N-of-1 trials: Individualized medication effectiveness tests

Virtual Mentor

Volumn 15, Issue 1, 2013, Pages 42-45

  Vohra, Sunita ^a   Punja, Salima ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); CROSSOVER PROCEDURE; DRUG THERAPY; HUMAN; METHODOLOGY; PERSONALIZED MEDICINE; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; CROSS-OVER STUDIES; DRUG THERAPY; HUMANS; INDIVIDUALIZED MEDICINE; TREATMENT OUTCOME;

EID: 84882251059     PISSN: 19377010     EISSN: None     Source Type: Journal    
DOI: 10.1001/virtualmentor.2013.15.1.stas2-1301     Document Type: Review

References (12)

1. Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?” Lancet. 2005;365(9453):82-93.
2. Guyatt G, Keller J, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med. 1990;112(4):293-299.
3. Guyatt G, Sackett D, Taylor D, Chong J, Roberts R, Pugsley S. Determining optimal therapy. Randomized trials in individual patients. N Engl J Med. 1986;314(14):889-892.
4. Forman AC, Vasey PA, Lincoln NB. Effectiveness of an adjustment group for brain injury patients: a pilot evaluation. Int J Ther Rehabil. 2006;13(5):223-228.
5. Nikles JN, Mitchell GK, Del Mar CB, Clavarino A, McNairn N. An n-of-1 trial service in clinical practice: Testing the effectiveness of stimulants for attention deficit/hyperactivity disorder. Pediatrics. 2006;117(6):2040-2046.
6. Nikles CJ, Yelland M, Glasziou PP, Del Mar C. Do individualized medication effectiveness tests (N-of-1 trials) change clinical decisions about which drugs to use for osteoarthritis and chronic pain? Am J Ther. 2005;12(1):92-97.
7. Smith BJ, Appleton SL, Veale AJ, McElroy HJ, Veljkovic D, Saccoia L. Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol. Chron Respir Dis. 2004;1(2):63-69.
8. Lashner BA, Hanauer SB, Silverstein MD. Testing nicotine gum for ulcerative colitis patients: Experience with single-patient trials. Dig Dis Sci.1990;35(7):827-832.
9. Paterson C. Measuring outcome in primary care: a patient-generated measure, MYMOP, compared to the SF-36 health survey. BMJ. 1996;312(7037):1016-1020.
10. Guyatt G, Sackett D, Adachi J, et al. A clinician’s guide for conducting randomized trials in individual patients. CMAJ. 1988;139(6):497-503.
11. Guyatt G, Heyting A, Jaeschke R, Keller J, Adachi JD, Roberts RS. N-of-1 randomized trials for investigating new drugs. Control Clin Trials. 1990;11(2):88-100.
12. Larson EB. N-of-1 trials: A technique for improving medical therapeutics. West J Med. 1990;152(1):52-56.